Regulatory Mechanism of MicroRNA Expression in Cancer

被引:887
作者
Ali Syeda, Zainab [1 ,2 ]
Langden, Siu Semar Saratu' [1 ,2 ]
Munkhzul, Choijamts [1 ,2 ]
Lee, Mihye [1 ,2 ]
Song, Su Jung [1 ,2 ]
机构
[1] Soonchunhyang Univ, Soonchunhyang Inst Medibiosci, Cheonan 31151, South Korea
[2] Soonchunhyang Univ, Dept Integrated Biomed Sci, Cheonan 31151, South Korea
基金
新加坡国家研究基金会;
关键词
microRNA; microRNA biogenesis; cancer; genetic alterations; epigenetic modification; post-transcriptional regulation; SOMATIC DICER1 MUTATIONS; BREAST-CANCER; DOWN-REGULATION; THERAPEUTIC TARGET; PROGESTERONE-RECEPTOR; TARBP2; MUTATION; ARGONAUTE; MIRNA; RNA; MYC;
D O I
10.3390/ijms21051723
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered gene expression is the primary molecular mechanism responsible for the pathological processes of human diseases, including cancer. MicroRNAs (miRNAs) are virtually involved at the post-transcriptional level and bind to 3 ' UTR of their target messenger RNA (mRNA) to suppress expression. Dysfunction of miRNAs disturbs expression of oncogenic or tumor-suppressive target genes, which is implicated in cancer pathogenesis. As such, a large number of miRNAs have been found to be downregulated or upregulated in human cancers and to function as oncomiRs or oncosuppressor miRs. Notably, the molecular mechanism underlying the dysregulation of miRNA expression in cancer has been recently uncovered. The genetic deletion or amplification and epigenetic methylation of miRNA genomic loci and the transcription factor-mediated regulation of primary miRNA often alter the landscape of miRNA expression in cancer. Dysregulation of the multiple processing steps in mature miRNA biogenesis can also cause alterations in miRNA expression in cancer. Detailed knowledge of the regulatory mechanism of miRNAs in cancer is essential for understanding its physiological role and the implications of cancer-associated dysfunction and dysregulation. In this review, we elucidate how miRNA expression is deregulated in cancer, paying particular attention to the cancer-associated transcriptional and post-transcriptional factors that execute miRNA programs.
引用
收藏
页数:18
相关论文
共 127 条
[1]   Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma [J].
Ahmadvand, Mohammad ;
Eskandari, Mahsa ;
Pashaiefar, Hossein ;
Yaghmaie, Marjan ;
Manoochehrabadi, Saba ;
Khakpour, Golnaz ;
Sheikhsaran, Fatemeh ;
Zohour, Mostafa Montazer .
LEUKEMIA RESEARCH, 2018, 70 :45-48
[2]   Intracytoplasmic Re-localization of miRISC Complexes [J].
Akgul, Bunyamin ;
Erdogan, Ipek .
FRONTIERS IN GENETICS, 2018, 9
[3]   Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia [J].
Allegra, D. ;
Bilan, V. ;
Garding, A. ;
Doehner, H. ;
Stilgenbauer, S. ;
Kuchenbauer, F. ;
Mertens, D. .
LEUKEMIA, 2014, 28 (01) :98-107
[4]   Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage [J].
Anglesio, M. S. ;
Wang, Y. ;
Yang, W. ;
Senz, J. ;
Wan, A. ;
Heravi-Moussavi, A. ;
Salamanca, C. ;
Maines-Bandiera, S. ;
Huntsman, D. G. ;
Morin, G. B. .
JOURNAL OF PATHOLOGY, 2013, 229 (03) :400-409
[5]   Extensive Promoter DNA Hypermethylation and Hypomethylation Is Associated with Aberrant MicroRNA Expression in Chronic Lymphocytic Leukemia [J].
Baer, Constance ;
Claus, Rainer ;
Frenzel, Lukas P. ;
Zucknick, Manuela ;
Park, Yoon Jung ;
Gu, Lei ;
Weichenhan, Dieter ;
Fischer, Martina ;
Pallasch, Christian Philipp ;
Herpel, Esther ;
Rehli, Michael ;
Byrd, John C. ;
Wendtner, Clemens-Martin ;
Plass, Christoph .
CANCER RESEARCH, 2012, 72 (15) :3775-3785
[6]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[7]   Understanding the tumor immune microenvironment (TIME) for effective therapy [J].
Binnewies, Mikhail ;
Roberts, Edward W. ;
Kersten, Kelly ;
Chan, Vincent ;
Fearon, Douglas F. ;
Merad, Miriam ;
Coussens, Lisa M. ;
Gabrilovich, Dmitry I. ;
Ostrand-Rosenberg, Suzanne ;
Hedrick, Catherine C. ;
Vonderheide, Robert H. ;
Pittet, Mikael J. ;
Jain, Rakesh K. ;
Zou, Weiping ;
Howcroft, T. Kevin ;
Woodhouse, Elisa C. ;
Weinberg, Robert A. ;
Krummel, Matthew F. .
NATURE MEDICINE, 2018, 24 (05) :541-550
[8]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[9]   Germline and somatic DICER1 mutations in familial and sporadic liver tumors [J].
Caruso, Stefano ;
Calderaro, Julien ;
Letouze, Eric ;
Nault, Jean-Charles ;
Couchy, Gabrielle ;
Boulai, Anais ;
Luciani, Alain ;
Zafrani, Elie-Serge ;
Bioulac-Sage, Paulette ;
Seror, Olivier ;
Imbeaud, Sandrine ;
Zucman-Rossi, Jessica .
JOURNAL OF HEPATOLOGY, 2017, 66 (04) :734-742
[10]   Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer [J].
Casey, M. C. ;
Prakash, A. ;
Holian, E. ;
McGuire, A. ;
Kalinina, O. ;
Shalaby, A. ;
Curran, C. ;
Webber, M. ;
Callagy, G. ;
Bourke, E. ;
Kerin, M. J. ;
Brown, J. A. .
BMC CANCER, 2019, 19 (1)